Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

atorvastatina

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

202 API Suppliers, 65 USDMF, 44 CEP/COS, 20 JDMF, 42 EU WC, 85 KDMF, 25 NDC API, 75 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

13 Drugs in Development

13 Drugs in Development

INTERMEDIATES

26 Intermediate Suppliers

26 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1623 FDF Dossiers, 187 FDA Orange Book, 799 Europe, 108 Canada, 99 Australia, 81 South Africa, 349 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 40MG BASE, TABLET;ORAL - EQ 80MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 10MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 20MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 40MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 80MG BASE, TABLET;ORAL - EQ 2.5MG BASE;EQ 10MG BASE, TABLET;ORAL - EQ 2.5MG BASE;EQ 20MG BASE, TABLET;ORAL - EQ 2.5MG BASE;EQ 40MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 10MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 20MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 40MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 80MG BASE

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 5 Evonik, 3 Rochem International Inc, 23 SPI Pharma, 18 DKSH, 1 Pharm-RX Chemical, 7 Faran Shimi Pharmaceutical, 2 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 2 Kewpie Corporation, 5 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 3 Pfanstiehl, 1 ACG Worldwide, 7 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 18 BASF, 1 BioSpectra, 12 Corel Pharma Chem, 7 DFE Pharma, 1 Finar, 10 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 20 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

89 Fillers, Diluents & Binders, 58 Coating Systems & Additives, 37 Direct Compression, 34 Disintegrants & Superdisintegrants, 34 Thickeners and Stabilizers, 30 Controlled & Modified Release, 27 Taste Masking, 24 Granulation, 24 Solubilizers, 21 Co-Processed Excipients, 21 Lubricants & Glidants, 20 Film Formers & Plasticizers, 20 Parenteral, 19 Topical, 19 Chewable & Orodispersible Aids, 13 Rheology Modifiers, 11 Emulsifying Agents, 8 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Surfactant & Foaming Agents

DIGITAL CONTENT

155 News #PharmaBuzz

155 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 662 Regulatory FDF Prices, 22 Annual Reports

MARKET PLACE

58 APIs, 21 FDF Dossiers, 1 Intermediates

PATENTS & EXCLUSIVITIES

5 US Patents, 72 Health Canada Patents

REF. STANDARDS & IMPURITIES

6 EDQM, 9 USP, 4 JP, 20 Others

ANALYTICAL

5 BioAnalytical Methods

5 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
04/06/2025	Centrient Pharmaceuticals	Netherlands	M/s Centrient Pharmaceuticals India Pvt Ltd	WC-0363	Atorvastatin Calcium IP/USP/BP/Ph. Eur	2025-04-21	2028-04-14	Bhai Mohan Singh Nagar, Toansa, Dist. SBS Nagar (Nawanshahr), Punjab -144533, India
04/06/2025	Dr. Reddy's Laboratories	India	M/s Dr Reddys laboratories Limited	WC-0390	Atorvastatin Calcium USP	2022-07-28	2025-12-30	Devunipalavalasa Village, Ranasthalam Mandal, Srikakulam District -532409, Andhra Pradesh, India

Atorvastatina

atorvastatina

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

202 API Suppliers

65 USDMF

44 CEP/COS

20 JDMF

42 EU WC

85 KDMF

25 NDC API

75 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

13 Drugs in Development

INTERMEDIATES

26 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1623 FDF Dossiers

187 FDA Orange Book

799 Europe

108 Canada

99 Australia

81 South Africa

349 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 10MG BASE

TABLET;ORAL - EQ 20MG BASE

TABLET;ORAL - EQ 40MG BASE

TABLET;ORAL - EQ 80MG BASE

TABLET;ORAL - EQ 10MG BASE;EQ 10MG BASE

TABLET;ORAL - EQ 10MG BASE;EQ 20MG BASE

TABLET;ORAL - EQ 10MG BASE;EQ 40MG BASE

TABLET;ORAL - EQ 10MG BASE;EQ 80MG BASE

TABLET;ORAL - EQ 2.5MG BASE;EQ 10MG BASE

TABLET;ORAL - EQ 2.5MG BASE;EQ 20MG BASE

TABLET;ORAL - EQ 2.5MG BASE;EQ 40MG BASE

TABLET;ORAL - EQ 5MG BASE;EQ 10MG BASE

TABLET;ORAL - EQ 5MG BASE;EQ 20MG BASE

TABLET;ORAL - EQ 5MG BASE;EQ 40MG BASE

TABLET;ORAL - EQ 5MG BASE;EQ 80MG BASE

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

5 Evonik

3 Rochem International Inc

23 SPI Pharma

18 DKSH

1 Pharm-RX Chemical

7 Faran Shimi Pharmaceutical

2 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

2 Kewpie Corporation

5 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

3 Pfanstiehl

1 ACG Worldwide

7 Actylis

2 Aeon Procare

1 Alcedo Pharmachem

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

18 BASF

1 BioSpectra

12 Corel Pharma Chem

7 DFE Pharma

1 Finar

10 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

7 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

39 Kerry

4 Kima Chemical

TABLET;ORAL - EQ 10MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 20MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 40MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 80MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons